Sinopharm seed industry and Syngenta work together to establish a joint laboratory for research and development of plant protection scheme of traditional Chinese Medicine

On January 15, 2020, Sinopharm Seed Industry Co., Ltd (hereinafter referred to as "Sinopharm seed industry") and Syngenta (China) Investment Co., Ltd (hereinafter referred to as "Syngenta") officially signed a strategic cooperation framework agreement in the biomedical base of Daxing District, Beijing on the joint organization and implementation of comprehensive solutions and market development projects for plant protection of Chinese herbal medicines During the meeting, the research and Development Laboratory of plant protection program for traditional Chinese medicine jointly established by Sinopharm seed industry and Syngenta was officially listed In the future, both sides will give full play to their respective advantages in the field of traditional Chinese medicine, learn from each other's strengths and complement each other's weaknesses, and achieve mutual benefit and win-win results, so as to provide high-quality traditional Chinese medicine for the development of the cause of traditional Chinese medicine in China Sinopharm Seed Industry Co., Ltd is the only state-owned enterprise in China to carry out seed and seedling management, technical service and quality inspection of traditional Chinese medicine, and build a national platform for seed and seedling breeding of traditional Chinese medicine It is not only the need of national development strategy, improving the quality of traditional Chinese Medicine and solving the source engineering problems, but also the need to assist the government to promote the breeding of traditional Chinese medicine seed and carry out joint research institutes It is an important cooperation platform for technology research and achievement transformation, and for promoting the healthy development of traditional Chinese medicine planting industry.